This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Stembiosys, Inc.. Active years: 2021-2025.
Company Filing History:
Years Active: 2021-2025
Title: Mary M Navarro: Innovator in Cell-Derived Extracellular Matrix Technology
Introduction
Mary M Navarro is a prominent inventor based in San Antonio, TX (US). She has made significant contributions to the field of biotechnology, particularly in the development of cell-derived extracellular matrices. With a total of 2 patents to her name, Navarro's work is paving the way for advancements in regenerative medicine.
Latest Patents
Navarro's latest patents focus on the creation and application of an amniotic fluid cell-derived extracellular matrix (ECM). This ECM is derived in vitro from cells isolated from amniotic fluid. The patents disclose methods for the isolation, maintenance, and proliferation of adherent cells, including stem cells, as well as techniques for the differentiation of these stem cells. This innovative approach has the potential to enhance therapeutic applications in various medical fields.
Career Highlights
Mary M Navarro is currently associated with Stembiosys, Inc., where she continues to advance her research and development efforts. Her work is instrumental in exploring new avenues for cell therapy and tissue engineering. Navarro's dedication to her field has established her as a key figure in the biotechnology sector.
Collaborations
Some of her notable coworkers include Edward S Griffey and Travis Block. Their collaborative efforts contribute to the innovative environment at Stembiosys, Inc., fostering advancements in cell-derived technologies.
Conclusion
Mary M Navarro's contributions to the field of biotechnology, particularly through her patents on cell-derived extracellular matrices, highlight her role as an influential inventor. Her work not only advances scientific knowledge but also holds promise for future medical applications.